Stock comparison
AMGEN INC is 17.6x more valuable than BIO-TECHNE Corp by market capitalization ($196.28 B vs $11.14 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
AMGN is larger
AMGEN INC is 17.6x more valuable than BIO-TECHNE Corp by market capitalization ($196.28 B vs $11.14 B).
Market value leader
AMGN
AMGEN INC is 17.6x more valuable than BIO-TECHNE Corp by market capitalization ($196.28 B vs $11.14 B).
Revenue leader
AMGN
TECH: $1.22B vs AMGN: $36.75B.
Profit leader
AMGN
TECH: $73.40M vs AMGN: $7.71B.
Margin leader
AMGN
TECH: 6.0% vs AMGN: 21.0% net margin.
| Metric | TECH | AMGN |
|---|---|---|
| Market cap | $11.14 B | $196.28 B |
| US-listed rank | #893 | #75 |
| Revenue (latest FY) | $1.22B | $36.75B |
| Net income (latest FY) | $73.40M | $7.71B |
| Net margin | 6.0% | 21.0% |
| P/E (trailing FY) | 151.8x | 25.5x |
| SEC filings | 1,229 | 1,011 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
AMGEN INC is 17.6x more valuable than BIO-TECHNE Corp by market capitalization ($196.28 B vs $11.14 B).
In their latest fiscal years, BIO-TECHNE Corp reported $1.22B in revenue while AMGEN INC reported $36.75B.
Full pages: BIO-TECHNE Corp and AMGEN INC, or browse the full rankings.